Last update Dec. 10, 2010

Rasagiline

Very High Risk

Very unsafe. Contraindicated. Use of an alternative or cessation of breastfeeding.

It a selective MAO-B inhibitor that increases Dopamine serum concentration and inhibits Prolactin secretion and hence decreasing the breast milk production.

Alternatives

We do not have alternatives for Rasagiline.

Suggestions made at e-lactancia are done by APILAM team, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Group

Rasagiline belongs to this group or family:

Tradenames

Main tradenames from several countries containing Rasagiline in its composition:

Pharmacokinetics

Variable Value Unit
Oral Bioavail. 36 %
Molecular weight 171 daltons
Protein Binding 70 %
Tmax 0,5 hours
T1/2 3 hours

References

We are working to add the scientific references of this product. It will be available soon. If you wish to have access to this information, please let us know by leaving your comment in the opinion section below.

Total visits

2,244

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by IHAN of Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM